SCHEMBL15079260

SCHEMBL15079260

C#C[C@]1(O)C(=C)C[C@H]2C3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 10/20 0.61
▸ LMNA P02545 5/20 0.61
▸ SMN1; SMN2 Q16637 6/20 0.58
▸ NR3C2 P08235 5/20 0.58
▸ NR3C1 P04150 3/20 0.58
▸ CYP2C19 P33261 3/20 0.58
▸ HSD17B10 Q99714 3/20 0.58
▸ PGR P06401 3/20 0.58
▸ SERPINA6 P08185 3/20 0.58
▸ CYP3A4 P08684 3/20 0.58
▸ SHBG P04278 3/20 0.58
▸ KMT2A Q03164 2/20 0.58
▸ MAPT P10636 2/20 0.58
▸ NFKB1 P19838 2/20 0.58
▸ HSD11B1 P28845 2/20 0.54
▸ HSD11B2 P80365 2/20 0.54
▸ AR P10275 2/20 0.54
▸ CHRM1 P11229 1/20 0.54
▸ TSHR P16473 2/20 0.52
▸ THRB P10828 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16387349 1.00 HIF1A (0.61) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL16387355 0.87 HIF1A (0.57) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL17591544 0.87 HIF1A (0.57) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL16387364 0.87 HIF1A (0.57) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL17634428 0.85 HIF1A (0.54) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL16389277 0.85 HIF1A (0.54) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL16387356 0.85 HIF1A (0.54) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL16387366 0.85 HIF1A (0.54) HIF1ALMNASMN1; SMN2NR3C2NR3C1
SCHEMBL10868441 0.84 SHBG (0.70) HIF1ALMNASMN1; SMN2NR3C1CYP2C19
SCHEMBL10892430 0.84 SHBG (0.70) HIF1ALMNASMN1; SMN2NR3C1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794632-B1 PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS CRYSTAL PHARMA SAU (ES) 2016-03-16 — — EP disclosed
WO-2013092668-A1 PROCESS FOR ALKYNYLATING 16-SUBSTITUTED-17-KETO STEROIDS CRYSTAL PHARMA, S.A.U. (ES) 2013-06-27 — — WO disclosed
Send feedback